Literature DB >> 29610062

Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review.

Dheyauldeen Shabeeb1, Masoud Najafi2, Gholamreza Hasanzadeh3, Mohammed Reza Hadian4, Ahmed Eleojio Musa5, Alireza Shirazi6.   

Abstract

INTRODUCTION: Peripheral neuropathy is one of the main complications of diabetes mellitus. One of the features of diabetic nerve damage is abnormality of sensory and motor nerve conduction study. An electrophysiological examination can be reproduced and is also a non-invasive approach in the assessment of peripheral nerve function. Population-based and clinical studies have been conducted to validate the sensitivity of these methods. When the diagnosis was based on clinical electrophysiological examination, abnormalities were observed in all patients.
METHOD: In this research, using a review design, we reviewed the issue of clinical electrophysiological examination of diabetic peripheral neuropathy in articles from 2008 to 2017. For this purpose, PubMed, Scopus and Embase databases of journals were used for searching articles. RESULTS/
FINDINGS: The researchers indicated that diabetes (both types) is a very disturbing health issue in the modern world and should be given serious attention. Based on conducted studies, it was demonstrated that there are different procedures for prevention and treatment of diabetes-related health problems such as diabetic polyneuropathy (DPN). The first objective quantitative indication of the peripheral neuropathy is abnormality of sensory and motor nerve conduction tests. Electrophysiology is accurate, reliable and sensitive. It can be reproduced and also is a noninvasive approach in the assessment of peripheral nerve function.
CONCLUSION: The methodological review has found that the best method for quantitative indication of the peripheral neuropathy compared with all other methods is clinical electrophysiological examination. For best results, standard protocols such as temperature control and equipment calibration are recommended.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Diabetes; Diabetic peripheral neuropathy; Electrophysiology; Nerve damage; Nervous system; Peripheral neuropathy

Mesh:

Year:  2018        PMID: 29610062     DOI: 10.1016/j.dsx.2018.03.026

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  11 in total

1.  Corroded Bolt Identification Using Mask Region-Based Deep Learning Trained on Synthesized Data.

Authors:  Quoc-Bao Ta; Thanh-Canh Huynh; Quang-Quang Pham; Jeong-Tae Kim
Journal:  Sensors (Basel)       Date:  2022-04-27       Impact factor: 3.847

2.  Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan.

Authors:  Kenji Sekiguchi; Nobuo Kohara; Masayuki Baba; Tetsuo Komori; Yutaka Naito; Tomihiro Imai; Jo Satoh; Yasuyuki Yamaguchi; Tatsuto Hamatani
Journal:  J Diabetes Investig       Date:  2018-08-09       Impact factor: 4.232

3.  The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study.

Authors:  Yimeng Hu; Qinge Li; Rui Min; Yingfeng Deng; Yancheng Xu; Ling Gao
Journal:  PeerJ       Date:  2021-01-13       Impact factor: 2.984

4.  Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis.

Authors:  Fahmida Haque; Mamun Bin Ibne Reaz; Sawal Hamid Md Ali; Norhana Arsad; Muhammad Enamul Hoque Chowdhury
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

5.  Clinical significance of apelin in the treatment of type 2 diabetic peripheral neuropathy.

Authors:  Hua Xu; Qi Wang; Qian Wang; Xuan Qiang Che; Xue Liu; Shumiao Zhao; Shitao Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

Review 6.  Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy.

Authors:  Baoyan Fan; Michael Chopp; Zheng Gang Zhang; Xian Shuang Liu
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

7.  Direct Comparison of Therapeutic Effects on Diabetic Polyneuropathy between Transplantation of Dental Pulp Stem Cells and Administration of Dental Pulp Stem Cell-Secreted Factors.

Authors:  Saki Kanada; Eriko Makino; Nobuhisa Nakamura; Megumi Miyabe; Mizuho Ito; Masaki Hata; Taisuke Yamauchi; Noritaka Sawada; Shun Kondo; Tomokazu Saiki; Tomomi Minato; Ken Miyazawa; Shigemi Goto; Tatsuaki Matsubara; Keiko Naruse
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

Review 8.  Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy.

Authors:  Josie Carmichael; Hassan Fadavi; Fukashi Ishibashi; Angela C Shore; Mitra Tavakoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

Review 9.  Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?

Authors:  Dalal Y Al-Bazz; Andrew J Nelson; Jamie Burgess; Ioannis N Petropoulos; Jael Nizza; Anne Marshall; Emily Brown; Daniel J Cuthbertson; Andrew G Marshall; Rayaz A Malik; Uazman Alam
Journal:  Diagnostics (Basel)       Date:  2022-03-17

10.  Role of interdigital sensory nerve conduction study as a noninvasive approach for early diagnosis of diabetic peripheral neuropathy.

Authors:  Hamid R Fateh; Seyed Pezhman Madani
Journal:  J Diabetes Metab Disord       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.